ConductScience.org, home

Trial · NCT04184375

Registered outcomes21

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryScore at the Frontal Assessment Battery (FAB)at 3 months after inclusion
The FAB assesses conceptualization (category responses, such as "in what way are a banana and an orange are alike?"), lexical fluency, programming or motor series (Luria), sensitivity to interference (conflicting instructions, such as "tap twice when I tap once"), inhibitory control (Go/No-Go), and environmental autonomy (prehension behavior, such as "do not take my hands")
SecondaryScore at FABat 6 months after inclusionScores between the 3-month and 6-month evaluation will determine whether executive analysis functions have been maintained
SecondaryNumber of patients with a positive difference between the scores on the Functional Activities Questionnaire (QAF)at inclusion
The QAF allows to quickly assess a patient's functional capacity and to identify a functional decline in the patient with a mild neurocognitive disorder, Alzheimer's disease or other neurocognitive disorder.
SecondaryNumber of patients with a positive difference between the scores on the Functional Activities Questionnaire (QAF)at 6 months after inclusionA positive difference in scores reflects an improvement in patient autonomy
SecondaryScore at delayed matching-to-sample (DMS48)at inclusionThe DMS48 is a test of visual recognition memory test
SecondaryScore at DMS48at 3 months after inclusionThe DMS48 is a test of visual recognition memory test
SecondaryTime in minutes at the Trail Making Test A (TMTA)at inclusionEvaluation of speed of processing.
SecondaryTime in minutes at the Trail Making Test Aat 3 months after inclusionEvaluation of speed of processing.
SecondaryNumber of errors at Trail Making Test B (TMTB)at inclusionEvaluation of mental flexibility
SecondaryNumber of errors at Trail Making Test B (TMTB)at 3 months after inclusionEvaluation of mental flexibility
SecondaryScore at ISAAC testat inclusionMeasures fluence
SecondaryScore at ISAAC testat 3 months after inclusionMeasures fluence
SecondaryScore at Montreal Cognitive Assessment (MMS)at inclusionAssessment for detecting cognitive impairment
SecondaryScore at Montreal Cognitive Assessment (MMS)at 6 months after inclusionAssessment for detecting cognitive impairment
SecondaryScore at the Hamilton Depression Rating Scaleat inclusionEvaluation of patient thymic state
SecondaryScore at the Hamilton Depression Rating Scaleat 6 months after inclusionEvaluation of patient thymic state
SecondaryInterference score at the Stroop testat inclusionEvaluation of selective attention
SecondaryInterference score at the Stroop testat 6 months after inclusionEvaluation of selective attention
SecondaryNumber of hospitalization due to relapseat 6 months after inclusionhospitalization due to relapse
SecondaryScore at Zarit scale (caregiver)at inclusionIdentification of suffering or exhaustion, anxiety and/or depressive disorder(s), sleep disorder(s), etc. in the caregiver

Source ClinicalTrials.govtrials-2026-11-12-0.4.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNone stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT04184375/registered